Dr. Kara B. Markham, MD
Maternal-Fetal Medicine (High-Risk Pregnancy) (Maternal & Fetal Medicine Physician)
At a glance
- Medical school
- University of Michigan Medical School (2005)
- Years since graduation
- 21
- In the NPI registry since
- 2007
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Medical school: University of Michigan Medical School
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Maternal & Fetal Medicine Physician primary
OH license 35090513 -
Obstetrics & Gynecology Physician
OH license 35090513
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Maternal-Fetal Medicine (High-Risk Pregnancy) per capita by county →
Where they work
Hospitals
- University of Cincinnati Medical Center, LLC Cincinnati, OH
Medical groups
- University of Cincinnati Physicians Company LLC (1,506 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 1 companies reported 22 payments worth $11,265 in total to this clinician.
| Janssen Research & Development, LLC | $11,265 |
|---|
| Travel and Lodging | $10,619 |
|---|---|
| Food and Beverage | $645 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Research & Development, LLC Nov 10, 2025 | Travel and Lodging travel to MADRID, Spain · in-kind | $7,160 |
| Janssen Research & Development, LLC Nov 10, 2025 | Travel and Lodging travel to MADRID, Spain · in-kind | $1,929 |
| Janssen Research & Development, LLC Oct 22, 2025 | Travel and Lodging travel to DALLAS, TX · in-kind | $719 |
| Janssen Research & Development, LLC Oct 22, 2025 | Travel and Lodging travel to DALLAS, TX · in-kind | $305 |
| Janssen Research & Development, LLC Oct 23, 2025 | Travel and Lodging travel to DALLAS, TX · in-kind | $305 |
| Janssen Research & Development, LLC Nov 10, 2025 | Travel and Lodging travel to MADRID, Spain · in-kind | $67.05 |
| Janssen Research & Development, LLC Oct 22, 2025 | Travel and Lodging travel to DALLAS, TX · in-kind | $48.21 |
| Janssen Research & Development, LLC Oct 24, 2025 | Travel and Lodging travel to DALLAS, TX · in-kind | $48.21 |
| Janssen Research & Development, LLC Nov 11, 2025 | Travel and Lodging travel to MADRID, Spain · in-kind | $20.49 |
| Janssen Research & Development, LLC Oct 23, 2025 | Travel and Lodging travel to DALLAS, TX · in-kind | $17.39 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $115,551 in research payments for these studies, mostly to the institutions running them.
- A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Nipocalimb in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Janssen Research & Development, LLC - A Historical Cohort, Multicenter Study to Characterize the Management, Clinical Course, and Outcomes of Pregnancies in Women Who Have Experienced a Pregnancy With Early Onset Severe HDFN
Janssen Research & Development, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.